ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT07024615: enrollment: not set → 25 participants.
REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07230834: enrollment: not set → 54 participants.
CRESCENT BIOPHARMA, INC. (CBIO)
Clinical trial NCT07335497: enrollment: not set → 290 participants.
BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT05599685 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2027-06-30 → 2025-09-16 3. primary completion date: 2027-06-30 → 2025-09-16 4. enrollment: not set → 302 participants
GILEAD SCIENCES, INC. (GILD)
Clinical trial NCT06167317: enrollment: not set → 278 participants.
REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT05989126: enrollment: not set → 35 participants.
MINERVA NEUROSCIENCES, INC. (NERV)
Clinical trial NCT07565428: enrollment: not set → 380 participants.
BAYER A.G. (BAYZF)
Clinical trial NCT07282847 updates: 1. start date: 2026-02-10 → 2026-04-15 2. enrollment: not set → 12 participants
BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT07223047: enrollment: not set → 252 participants.
ASTRAZENECA PLC (AZN)
Clinical trial NCT07338942 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-30 → 2026-04-21 3. enrollment: not set → 4000 participants